99% Purity Mazdutide in Stock cas 2259884-03-0
5 Inquiries
2259884-03-0
Pharmaceutical Grade
99%
guangzhou
DL
10mg/vial,10vials/box
Yes
2027-03-31
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,Bacteriostatic wate
-
Product Details
-
Seller Information
-
History Price
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Mazdutide is a peptide-based GLP-1 and glucagon receptor (GCGR) dual agonist. As a pharmaceutical raw material, Mazdutide is characterized by its dual receptor activity and defined peptide structure. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
Basic Info-
Product Name:
Mazdutide
Other Name:Mazdutide;Mazdutide acetate;Mazdutide 10mg;Mazdutide 5mg 10mg;LY-3305677;Mazdutide (IBI-362;OXM-3)
CAS No.:2259884-03-0
Molecular Weight:0
EC Number:884-103-0
Color/Form:White to off-white
Categories:
Research-
Class:
Dual GLP-1R/GCGR agonist (long-acting peptide)
Status:Investigational — Phase 3 (China)
Mechanism:A long-acting dual agonist of the GLP-1 receptor (GLP-1R, Ki = 28.6 nM) and glucagon receptor (GCGR, Ki = 17.7 nM). The dual activation provides both glycemic control (via GLP-1R) and increased energy expenditure / hepatic lipolysis (via GCGR), producing weight loss beyond what GLP-1R agonism alone achieves.
EC50 (GLP1R Ki):28.6 nM
EC50 (GCGR Ki):17.7 nM
Source:GlpBio: Mazdutide (CAS 2259884-03-0); Innovent Phase Ib results (eClinicalMedicine 2022).DOI
Clinical Development:
References-
PubChem:Literature:
GlpBio: Mazdutide (CAS 2259884-03-0); eClinicalMedicine: Innovent Phase Ib results (2022); ClinicalTrials.gov: DREAMS-1 (NCT04930343)
Disclaimer:Mazdutide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials in China. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,Bacteriostatic wate
-
Location:
Jinxing Middle Road, Xihu Street, Yuelu District, Changsha City, Hunan Province
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment
-
Average lead Time:
2 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2023
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted
United States
Mazdutide
25 MG Aug 12, 2026
Nigeria
Mazdutide 10mg
20 PCS Mar 7, 2026
United Kingdom
Mazdutide
1 KG Feb 10, 2026
United States
Mazddultide cas
2 MT Nov 14, 2025
United States
Mazdutide
30 MG Jul 15, 2024 Post an enquiry for this product
More from this Seller
-
-
-
Wholesale Price PEG MGF CAS 108174-48-7 Customized Peptides 5mg
Pharmaceutical Grade / 99%
-
-
-
-
CAS 307297-39-8 Weight Loss Peptides Epitalon Epithalon for Sale 15mg
Cosmetics Grade / 99%
$120/UNIT FOB
-
-
-
-
Supply High Purity Vial Peptide Selank Semax Relief Memory
Pharmaceutical Grade / 99%
$70.99/UNIT FOB
-
-
-
-
Weight Loss Peptides Cagrilintide Tirz Reta Retatrutide Fox-04-Dir Nad Adipotide Customized Peptides 2mg/5mg
Pharmaceutical Grade / 99%
$85/UNIT FOB
-
-
-
-
99%Slimming Bodyshaping Peptide Powder 5mg 10mg 15mg 20mg 30mg Anti-Obesity Lyophilized Peptides Semaglutide Weight Loss Peptide
Industrial Grade / 99%
$68/UNIT FOB
-
-
-
-
Cosmetic Melanotan I Skin Tanning Melanotan I Raw Material Powder Melanotan 1 Mt 2
Pharmaceutical Grade / 99%
-